ライフサイエンスコーパス: core biopsy

1 believed to have been accurately sampled at core biopsy.

2 cal mp-MR followed by MR-guided stereotactic core biopsy.

3 ignant lesions) were sampled at large-needle core biopsy.

4 (7.7%) were diagnosed by FNA or stereotactic core biopsy.

5 f breast lesions removed during stereotactic core biopsy.

6 cancers and 12 in situ cancers, compared to core biopsy.

7 mas preoperatively sampled with stereotactic core biopsy.

8 consecutive women who underwent stereotaxic core biopsy.

9 ocal lesion of the pancreas, qualified for a core biopsy.

10 lesions seen on PET followed by standard 12-core biopsy.

11 sy quality, defined as tumor fraction in the core biopsy.

12 ical subtype, which was definitely proved at core biopsy.

13 rostate tissue before the initial systematic core biopsy.

14 esions underwent US or DCE MR imaging-guided core biopsy.

15 se chain reaction (PCR) to detect KSHV in BM core biopsies.

16 quently, the lungs were cut and sampled with core biopsies.

17 e, and feasibility of obtaining preoperative core biopsies.

18 sampling and could help improve the yield of core biopsies.

19 3 + 4) compared with standard (systematic 12-core) biopsies.

20 sclerosing adenosis was the major finding at core biopsy (21 lesions at 14-gauge core biopsy and 12 a

21 ession by the osteoblasts in all bone marrow core biopsies (352 of 352, 100%).

22 en by either fine-needle aspiration (19/59), core biopsy (39/59), or lumpectomy (8/59) underwent SLN

23 r tissue typically recovered from a standard core biopsy (5-20 mg) and may be applied to tissues of o

24 re reimbursement costs of +385 for US-guided core biopsy, +610 for stereotactic core biopsy, and +1,3

25 s is the endothelial injury seen on protocol core biopsies after implantation.

26 were collected for 1121 patients undergoing core biopsies and 501 patients undergoing surgical biops

27 on possible from routine stereotactic needle core biopsies and perform highly resolved multi-omics an

28 Targeted core biopsies and random systematic core biopsies were p

29 and resolution without the need for invasive core biopsies and substantially improve early detection

30 or versus smaller core was stronger with two core biopsies and was not further strengthened with addi

31 age, 54 years) were excised by using FNA and core biopsies and were collected between September 7, 20

32 Medicare estimates of $472 for stereotactic core biopsy and $1,335 for surgical biopsy.

33 4% (76 of 373) of lesions diagnosed at large-core biopsy and 11.2% (107 of 953) of lesions diagnosed

34 nding at core biopsy (21 lesions at 14-gauge core biopsy and 12 at 11-gauge vacuum-assisted biopsy);

35 y, the cost would be reduced by 20% with the core biopsy and 39% with the sestamibi strategy.

36 ADH, 1058 (61.3%) of which were diagnosed by core biopsy and 635 (36.8%) by excisional biopsy.

37 t in 26 (48%) of 54 lesions sampled at large-core biopsy and in 13 (18%) of 74 lesions sampled at vac

38 rating carcinoma diagnosed with percutaneous core biopsy and obviated axillary dissection in 23 women

39 mpared sestamibi breast imaging, stereotaxic core biopsy and surgical biopsy as breast evaluation str

40 lated images with the histologic findings at core biopsy and then designating each core biopsy findin

41 ortant unaccepted difference of PPV3 between core biopsy and vacuum-assisted biopsy, which needs furt

42 US-guided core biopsy, +610 for stereotactic core biopsy, and +1,332 for needle localization and surg

43 as inadvertently removed during stereotactic core biopsy, and a 0.5- or 1.0-cm-long endovascular embo

44 phyllodes tumors (BPTs) present as an FEL on core biopsy, and these lesions along with any lesions wi

45 Fine-needle aspiration biopsy and core biopsy are important procedures that may obviate su

46 between a larger tumor specimen and smaller core biopsies based on number and location (central tumo

47 osed with hepatocellular carcinoma by tissue core biopsy before treatment initiation, a Liver Imaging

48 -SIM images of 34 unfixed and uncut prostate core biopsies by two independent pathologists resulted i

49 Multiple FFPE core biopsies can be assembled in a single block to form

50 Image-guided core biopsy can be cost-saving compared with surgical bi

51 dance is achieved, women with ALH or LCIS at core biopsy can be observed.

52 for women whose ADH was diagnosed by needle core biopsy compared with excisional biopsy.

53 An initial core biopsy confirmed carcinoma in the breast.

54 A core biopsy confirmed invasive ductal carcinoma, grade 2

55 ostic imaging reveals a suspicious mass, and core biopsy confirms invasive ductal carcinoma (IDC) tha

56 graphic database review (1994-2003) revealed core biopsy diagnoses of benign papilloma (n=38), atypic

57 2 patients with ADH or benign but discordant core biopsy diagnoses.

58 went sentinel node biopsy after percutaneous core biopsy diagnosis of nonpalpable infiltrating breast

59 Core biopsy did not reveal malignancy in any of the nine

60 From the initial core biopsies, differential patterns of expression of 92

61 on, patients were randomly assigned to tumor core biopsy either before the first dose or after the th

62 ammography, ultrasonography, core technique, core biopsy, excision, and subsequent mammography.

63 ngs at core biopsy and then designating each core biopsy finding as concordant or discordant.

64 Vacuum-assisted core biopsy findings were compared with excisional biops

65 nce was observed in the likelihood of benign core biopsy findings without atypia in malignant calcifi

66 Of the 43 benign concordant core biopsy findings, none were upgraded at surgery (n =

67 Magnetic resonance images and core biopsy findings.

68 ng women diagnosed with DCIS on the basis of core biopsy findings.

69 le on ultrasound follow-up for one year when core-biopsy findings indicated benignity.

70 ultrasound follow-up in patients with benign core-biopsy findings.

71 g adenosis proved to be a minor component at core biopsy for 44 lesions, including one invasive ducta

72 assisted 11- or 14-gauge needle stereotactic core biopsy for calcifications with malignant histologic

73 A renal core biopsy for histological evaluation is the gold stan

74 ined biopsy (targeted biopsy and standard 12-core biopsy) for men with positive imaging results, and

75 Core biopsies from 24 patients were obtained before trea

76 We studied paraffin-embedded bone marrow core biopsies from 39 patients with HCL in complete remi

77 We digitised 6682 slides from needle core biopsies from 976 randomly selected participants ag

78 ials and Methods All 9-gauge vacuum-assisted core biopsies from a single tertiary breast center that

79 was performed on tissue microarrays from 652 core biopsies from BC patients, who underwent NACT in th

80 Histological review was performed on liver core biopsies from native livers.

81 ates in transplant fine-needle aspirates and core biopsies from patients on this regimen without acut

82 thms based on magnetic resonance imaging and core biopsy guide treatment redirection after each block

83 magnetic resonance imaging volume change and core biopsy guide treatment redirection after each block

84 ng history, lesion size, use of an automated core biopsy gun, number of needle passes, and frequency

85 The core biopsies had lymphocytes in 5-30% of the interstiti

86 Sites were re-entered at 20 weeks for bone core biopsy harvesting and subsequent implant placement.

87 o seems that the tissue material obtained by core biopsy has higher diagnostic potential than that ob

88 opulation, one third of patients with ADH at core biopsy have an occult carcinoma.

89 nosis of DCIS after 14-gauge automated large-core biopsy in 373 lesions and after 14- or 11-gauge dir

90 esions in seven institutions and after large-core biopsy in 55 previously reported lesions.

91 he sensitivity, specificity, and accuracy of core biopsy in differentiating neoplastic (malignant and

92 The role of image-guided core biopsy in nonpalpable breast lesion evaluation is b

93 US-guided core biopsy in patients with head and neck lymphadenopat

94 f the study was to analyse the usefulness of core biopsy in the diagnosis of malignant neoplasms of t

95 ve in 16% (30 of 182) of lesions at 14-gauge core biopsy, in 4% (four of 96) of lesions at 14-gauge v

96 ochemical studies previously obtained on the core biopsy indicated that the tumor was positive for es

97 quencing of single-cell nuclei from prostate core biopsies is a rich source of quantitative parameter

98 Benign papilloma diagnosed at core biopsy is infrequently (3%) associated with maligna

99 Core biopsy is necessary if a diagnosis cannot be made w

100 Moving to a policy in which core biopsy is the preferred approach in these settings

101 bx), stereotactic 11-gauge suction-assisted core biopsy (Mammotome [Mbx]), stereotactic coring excis

102 od, use of minimally invasive methods (e.g., core biopsy) may be desirable for obtaining tissue sampl

103 um-assisted biopsy (mean, 34 mg) as at large-core biopsy (mean, 17 mg) (previously reported).

104 biopsy (mean, 15.8 specimens) than at large-core biopsy (mean, 9.7 specimens).

105 success rate with the traditional 14-gauge, core-biopsy, multiple-pass technique was compared with t

106 e, marital status, overall health, number of cores biopsied, NCCN risk group, and treatment type, rur

107 ecimens with known activity obtained using 2 core-biopsy needle sizes.

108 pling of brain, lung, and liver tissue using core biopsy needles, blood and cerebrospinal fluid colle

109 anced neuroblastoma by using 15- or 16-gauge core biopsy needles.

110 by competitive RT-PCR in 60 renal allograft core biopsies obtained for surveillance or to diagnose t

111 Core biopsies obtained using PET/CT guidance contain bou

112 US-guided core biopsy obviated a surgical procedure in 128 (85%) o

113 ermine the frequency with which stereotactic core biopsy obviated a surgical procedure.

114 Sixty-three CT-guided core biopsies of 42 pancreas grafts were performed with

115 May 3, 1994, and June 12, 1996, image-guided core biopsies of 510 mammographically identified lesions

116 Core biopsies of bone marrow showed a mean of 0.0029+/-0

117 Core biopsies of grafted areas were obtained in several

118 safety and quality outcomes for percutaneous core biopsies of hepatocellular carcinoma (HCC) performe

119 disease (MRD) can be detected in bone marrow core biopsies of patients with hairy cell leukemia (HCL)

120 Endobronchial ulstrasound-guided core biopsies of the lung mass and ipsilateral mediastin

121 Stereotactic core biopsy of a 4-5-mm, suspicious mammographic lesion

122 lerosing adenosis is an acceptable result at core biopsy of circumscribed masses and nonpalpable indi

123 Subsequently, a core biopsy of intrahepatic colorectal metastases was pe

124 was found for fine-needle aspiration versus core biopsy of malignant lesions (92% vs 86%), a statist

125 A 51-year-old woman underwent stereotactic core biopsy of suspicious microcalcifications in the upp

126 r density by morphometric analysis of needle core biopsy of the donated kidney and wedge sections of

127 Core biopsy of the involved lymph node confirmed estroge

128 efore surgical resection, followed by needle-core biopsy of the optically measured tissue.

129 The Mayo Clinic diagnostic strategy utilizes core biopsy of the pancreas and the Japanese strategy de

130 A core biopsy of tumor and normal adjacent liver by using

131 ons, 18 (25%) were diagnosed as malignant at core biopsy; one (1%), as premalignant; 30 (42%), as spe

132 Sensitivity analysis showed core biopsy optimal in 95.4% of trials.

133 The projected cost savings of core biopsy or sestamibi imaging, compared to surgery, r

134 cost savings were realized with stereotactic core biopsy over open surgical biopsy for all mammograph

135 Overall cost savings for stereotactic core biopsy over open surgical biopsy was $741 per case.

136 a half to three times higher than those for core biopsy (P < .001).

137 Rapid assessment of prostate core biopsy pathology at the point-of-procedure could pr

138 nderwent 60 biopsy events with a median of 8 core biopsies per procedure (interquartile range, IQR, 7

139 to the results of one, two, and three 0.6-mm core biopsies per tumor on a tissue array.

140 ate of stereotactic vacuum-assisted 11-gauge core biopsies performed (P < .001).

141 al triglyceride extraction (n=117), and five core biopsies performed in each segment for histologic g

142 er, the study of complex tissues using small core biopsies presents many technical challenges.

143 rized using the invasive percutaneous needle core biopsy procedure.

144 onse was assessed in 3-week post-therapeutic core biopsies (proliferation decrease >/= 30% Ki-67 or c

145 Patients with core biopsy-proven concordant fibroadenomas do not requi

146 There was strong consensus that core biopsy-proven concordant fibroadenomas without atyp

147 e randomized to either a standard (random 12-core biopsy; RB) group or an image-guided biopsy (IGB) g

148 After a diagnosis of lobular neoplasia at core biopsy, residual microcalcifications are viewed in

149 s a patient with a growing breast lump whose core biopsy result was suspicious for breast cancer.

150 concentration (tHb) and was correlated with core biopsy results.

151 Histological evaluation of the human bone core biopsies revealed normal bone tissue formation iden

152 Of 31 patients, stereotactic core biopsy revealed carcinoma in 19 (61%), atypical duc

153 %) were deemed poor donor candidates because core biopsy revealed subtle hepatic necrosis and nonspec

154 ostic ultrasound confirms a 1.8 cm mass, and core biopsy reveals IDC that is estrogen and progesteron

155 Triplicate 0.6-mm core biopsies sampled on tissue arrays provide a reliabl

156 Nineteen of 38 core biopsy samples contained cancer.

157 We took core biopsy samples from primary breast tumours in 24 pa

158 ence of an association between the number of core biopsy samples obtained and any postprocedural comp

159 s are detected when increasing the number of core biopsy samples per index lesion from one to three a

160 Ten full-depth core biopsy samples were obtained from patients who had

161 The number of core biopsy samples, glomeruli, and small arteries obtai

162 From the core biopsy samples, we extracted sufficient total RNA (

163 ent-derived xenografts were established from core biopsy samples.

164 Core-biopsy samples of normal bone marrow from the iliac

165 The MITS included needle core-biopsy sampling for histopathology of brain, lung,

166 tage of TILs using hematoxylin-eosin-stained core biopsy sections taken at diagnosis (prior to treatm

167 cy (67%), diagnosis of atypical papilloma at core biopsy should prompt excision for definitive diagno

168 Stereotactic core biopsy showed a focus of invasive duct carcinoma, s

169 Nine core biopsies showing interstitial lymphocytic infiltrat

170 ant EBV-TK mRNA expression in a stereotactic core biopsy specimen from a solid organ transplant patie

171 vessels per millimeter length of bone marrow core biopsy specimen was scored by light microscopy.

172 nalyzed using tissue microarrays from needle core biopsy specimens and xenograft-bearing mouse models

173 Histologic results from core biopsy specimens determined the lesions to be benig

174 uantified angiogenesis alone in pretreatment core biopsy specimens did not predict treatment response

175 uencing on laser capture microdissection and core biopsy specimens from formalin-fixed paraffin-embed

176 es were analyzed using surgical material and core biopsy specimens from HCV-infected cirrhotic liver

177 The utility of saving core biopsy specimens in sterile gel tubes was evaluated

178 ow the detection of prostate cancer cells in core biopsy specimens with insufficient numbers of cells

179 (PgR) percentage expression (46 surgical, 2 core biopsy specimens) was performed.

180 as available for 44 patients (42 surgical, 2 core biopsy specimens).

181 serum PSA level, percentage of cancer in all core biopsy specimens, and endorectal MR imaging finding

182 age of cancer-positive core specimens in all core biopsy specimens, and presence of perineural invasi

183 tumor, greatest percentage of cancer in all core biopsy specimens, percentage of cancer-positive cor

184 ompared with tissue diagnoses from US-guided core biopsy specimens.

185 Performing QABS on core-biopsy specimens obtained using PET/CT guidance ena

186 ications, 1.8 times more frequent with large-core biopsy than with vacuum-assisted biopsy, and 1.5 ti

187 There were 9 needle-localized core biopsies that corresponded to MRI of metastatic les

188 develop prognostic factors derived from the core biopsy that may enhance the prediction of tumor bio

189 nderwent percutaneous CT-guided coaxial lung core biopsy, there was no evidence of an association bet

190 e identified 293 probe sets overexpressed in core biopsies; these included five highly coexpressed ge

191 -needle aspiration biopsy (eight lesions) or core biopsy (three lesions).

192 and Jones silver stain) using kidney needle core biopsy tissue sections.

193 rchives contain thousands of paraffinized BM core biopsy tissue specimens, providing a rich resource

194 We used immunohistochemistry in bone marrow core biopsies to assess NCAM expression in osteoblasts a

195 reserved blood from 234 men referred for 10+ core biopsy to Aarhus University Hospital, 29 with PSA &

196 The results show core biopsy to be a sensitive, accurate, and safe method

197 tent malignancy is necessary for stereotaxic core biopsy to be optimally effective.

198 ry, histologic grading, and the relevance of core biopsy to diagnostic certainty are considered.

199 e 19 patients with carcinoma at stereotactic core biopsy, two chose to undergo a second biopsy surgic

200 rgical biopsy, one with DCIS at stereotactic core biopsy underwent axillary dissection after invasion

201 assisted biopsy, ultrasonography (US)-guided core biopsy, US-guided fine-needle aspiration biopsy, su

202 Here we report a proteogenomics approach for core biopsies using tissue-sparing specimen processing a

203 by percutaneous image-guided vacuum-assisted core biopsy (VACB).

204 an adjusted direct cost saving per US-guided core biopsy was +744 per case.

205 gnancy can be seen with sclerosing adenosis; core biopsy was accurate in six (86%) of seven coexisten

206 Diagnosis at stereotactic core biopsy was carcinoma in 116 (81%) lesions, atypical

207 Core biopsy was favored for low-suspicion lesions, calci

208 and at the time of implant placement, a bone core biopsy was harvested followed by dental implant pla

209 urned for implant placement and an 8-mm bone core biopsy was harvested using a trephine drill during

210 yielded atypical hyperplasia at stereotactic core biopsy was higher for calcifications than masses (3

211 , clinical measurements were repeated, and a core biopsy was obtained and prepared for histologic eva

212 s (average: 18.2 weeks), and a 2-mm-diameter core biopsy was obtained before implant placement.

213 e reentered at the appropriate healing time, core biopsy was obtained, and a dental implant was place

214 US-guided core biopsy was performed in 151 consecutive solitary, n

215 ny test result was positive, a systematic 12-core biopsy was performed.

216 Per 1000 women, core biopsy was projected to miss about seven invasive a

217 A 2-mm-diameter core biopsy was taken from each grafted site approximate

218 Fine-needle aspiration (FNA) or stereotactic core biopsy was used to diagnose 195 of the 422 patients

219 Stereotactic core biopsy washings and blood drop samples, routinely d

220 keratin-positive (epithelial) cells from the core biopsy washings were sorted by means of flow cytome

221 Core biopsies were assessed by immunohistochemistry for

222 At the time of implant placement, bone core biopsies were harvested using the radiographic-surg

223 ed to heal for 18 to 20 weeks, at which time core biopsies were obtained and dental implants were pla

224 Breast core biopsies were obtained at baseline and after 2 mont

225 Approximately 20 weeks after grafting, core biopsies were obtained during implant placement and

226 al measurements were performed, and trephine core biopsies were obtained for histomorphometric analys

227 linical measurements were repeated, and bone core biopsies were obtained for histomorphometric analys

228 Under image guidance, 18G core biopsies were obtained using coaxial technique at t

229 Two hundred sixty US-guided core biopsies were performed in 247 patients with cervic

230 Targeted core biopsies and random systematic core biopsies were performed.

231 Sequential core biopsies were taken at baseline and within weeks 1

232 Core biopsies were taken at diagnosis in patients with H

233 Histologic findings at core biopsy were correlated with mammographic findings,

234 olitary invasive breast cancers diagnosed at core biopsy were treated with US-guided cryoablation and

235 ined biopsy (targeted biopsy and standard 12-core biopsy) were simultaneously reduced by 20 percentag

236 or detecting transplant rejection involves a core biopsy, which is invasive, has limited predictive p

237 etting, then sestamibi imaging or sterotaxic core biopsy will lead to substantial cost savings compar

238 rmalin-fixed, paraffin-embedded tissues from core biopsies with a tumor cell content of >/= 20% by us

239 Stereotactic core biopsy with an automated gun obviated a surgical pr

240 ications who underwent 14-gauge stereotactic core biopsy with an automated gun.

241 ably at vacuum-assisted biopsy than at large-core biopsy (with no increase in complications) with mos

242 ductal carcinoma considered grade 2 of 3 on core biopsy, with a positive fine-needle aspiration of a

243 Two hundred thirty-eight (92%) core biopsies yielded adequate material.

244 database was searched from 2000 to 2010 for core biopsies yielding ALH or LCIS devoid of any additio